| Hsa-miR-3202 attenuates Jurkat cell infiltration via MMP2 in primary Sjogren's syndrome. | Hsa-miR-3202 attenuates Jurkat cell infiltration via MMP2 in primary Sjögren's syndrome.
Gao Q, Ye Z, Liu T, Jiang J, Jiang Z, Cao D, Zhao L. | 10/22/2022 |
| Antiapoptotic Protein FAIM2 is targeted by miR-3202, and DUX4 via TRIM21, leading to cell death and defective myogenesis. | Antiapoptotic Protein FAIM2 is targeted by miR-3202, and DUX4 via TRIM21, leading to cell death and defective myogenesis.
Soliman HAN, Toso EA, Darwish IE, Ali SM, Kyba M., Free PMC Article | 04/30/2022 |
| results suggest that high level miR-3202 in T lymphocytes may protect epithelial cells through targeting FAIM2. MiR-3202 might be used as a notable biomarker of chronic obstructive pulmonary disease . | MiR-3202 protects smokers from chronic obstructive pulmonary disease through inhibiting FAIM2: An in vivo and in vitro study.
Shen W, Liu J, Fan M, Wang S, Zhang Y, Wen L, Wang R, Wei W, Li N, Zhang Y, Zhao G. | 10/6/2018 |
| An association between the rs188912830 gene variant of miR3202 that targets the MeCP2 protein and lung cancer (LC) was indicated in both subtypes. The rs318039 gene variant of miR1274 that targets DNMT3b was found to be associated with LC subtypes. | miRSNPs of miR1274 and miR3202 Genes that Target MeCP2 and DNMT3b Are Associated with Lung Cancer Risk: A Study Conducted on MassARRAY Genotyping.
Ozbayer C, Degirmenci I, Ustuner D, Ak G, Saydam F, Colak E, Gunes HV, Metintas M. | 02/18/2017 |